Home / Journals / CJU / Vol.13, No.4, 2006
Special Issues
Table of Content
  • Open AccessOpen Access

    ARTICLE

    Robot-assisted radical prostatectomy in obese patients

    Judd Boczko1, Ralph Madeb1, Dragan Golijanin1, Erdal Erturk1, Mary Mathe1, Hitendra R. H. Patel2, Jean V. Joseph1
    Canadian Journal of Urology, Vol.13, No.4, pp. 3169-3173, 2006
    Abstract Objectives: Few centers perform extraperitoneal robot assisted radical prostatectomy. The average patient weight is increasing to the mildly obese. Little is known as to the difficulty-impact obesity may have on robot-assisted extraperitoneal prostatectomy (RAP). We assess our own experience with obese patients undergoing RAP.
    Materials and methods: Information on 375 consecutive patients undergoing robot-assisted extraperitoneal prostatectomy by a single surgeon was gathered. Obesity is defined as having a body mass index (BMI) greater than 30 kg/m². Patients with BMI ≥30 were compared to those with BMI <30. Specific comparators between the groups were: age, total operating time,… More >

  • Open AccessOpen Access

    ARTICLE

    Prevalence and occurrence of stress urinary incontinence in elite women athletes

    Nicolas Caylet1, Pascale Fabbro-Peray2, Pierre Marès3, Michel Dauzat4, Dominique Prat-Pradal1, Jacques Corcos5
    Canadian Journal of Urology, Vol.13, No.4, pp. 3174-3179, 2006
    Abstract Objective: 1) To assess the prevalence of stress urinary incontinence (SUI) and urge urinary incontinence (UTI) in elite women athletes versus the general female population, and 2) to analyze the conditions of occurrence of urine loss in search of etiological clues in elite athletes.
    Design: An anonymous self-questionnaire was collected transversally from women aged 18 to 35 years. The exposed group was composed of elite female athletes; the non-exposed group was made up of women in the same age range accepting to answer the questionnaire.
    Results: A total of 157 answers from elite athletes and 426 from… More >

  • Open AccessOpen Access

    ARTICLE

    The use of bisphosphonates in men with hormonerefractory prostate cancer: a systematic review of randomized trials

    Scott Berry1, Tricia Waldron2, Eric Winquist3, Himu Lukka4, on behalf of the Cancer Care Ontario Program in Evidence-based Care’s Genitourinary Cancer Disease Site Group5
    Canadian Journal of Urology, Vol.13, No.4, pp. 3180-3188, 2006
    Abstract Purpose: A systematic review of randomized controlled trials (RCTs) was performed to assess the benefits of bisphosphonate therapy in men with hormone-refractory prostate cancer (HRPC).
    Methods: The literature was searched to identify RCTs or meta-analyses comparing treatment with bisphosphonates to placebo or no treatment.
    Results: Ten trials that studied clodronate (five trials, 404 patients), pamidronate (two trials, 350 patients), alendronate (one trial, 49 patients), etidronate (one trial, 51 patients), and zoledronic acid (one trial, 643 patients) in men with HRPC and bone metastases met the eligibility criteria. Pain response was the most frequently reported primary outcome (eight… More >

  • Open AccessOpen Access

    ARTICLE

    Treatment of BCG failures with intravesical BCG/ Interferon: the University of Montreal experience

    Pierre I. Karakiewicz1, Serge Benayoun1,2, Daniel J. Lewinshtein1,2, Felix K.-H. Chun1, Khaled Shahrour2, Paul Perrotte2
    Canadian Journal of Urology, Vol.13, No.4, pp. 3189-3194, 2006
    Abstract Objective: Bacillus Calmette-Guerin (BCG) has shown promise in large scale studies. We assessed recurrencefree survival in patients treated with intravesical BCG/ Interferon (IFN) for non-muscle invasive, BCG refractory, transitional cell carcinoma (TCC) of the urinary bladder at our local institution. Methods: Cancer control data were gathered for patients enrolled in a BCG/Interferon protocol at the University of Montreal. The main inclusion criteria consisted of pathologically proven evidence of intravesical BCG failure, and of complete transurethral resection of latest post BCG recurrence. Induction consisted of eight intravesical BCG/Interferon instillations. Select patients were treated with BCG/Interferon maintenance… More >

  • Open AccessOpen Access

    HOW I DO IT

    Does indigo carmine prevent early artificial urinary sphincter cuff erosion?

    Steven P. Petrou, David D. Thiel, Daniel S. Elliot, Gregory A. Broderick, Michael J. Wehle, Paul R. Young
    Canadian Journal of Urology, Vol.13, No.4, pp. 3195-3198, 2006
    Abstract Introduction: Urethral erosion following artificial urinary sphincter (AUS) placement is hypothesized to be secondary to unrecognized intra-operative urethral injury. Intra-urethral indigo carmine solution (ICS), a blue dye, following urethral mobilization should identify intra-operative urethrotomy and prevent early post-operative cuff erosion.
    Methods: Retrospective review was completed of all men undergoing AUS (AMS 800 device) insertion between January 2000 and January 2005 for post prostatectomy stress incontinence at one institution. Operative reports were examined for use of intra-operative injection of ICS as well as documentation of urethral injury. Post-operative course was reviewed for evidence of early cuff erosion.… More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Sclerosing mesenteritis progressing to ureteral obstruction

    Scott Manatt, Adam Metwalli, Daniel J. Culkin
    Canadian Journal of Urology, Vol.13, No.4, pp. 3199-3200, 2006
    Abstract Sclerosing mesenteritis is part of a spectrum of benign, inflammatory diseases of the abdominal mesentery. It has been called retractile mesenteritis, and other forms include mesenteric panniculitis and mesenteric lipodystrophy. The disease rarely involves the retroperitoneum. We present a case of sclerosing mesenteritis that progressed to ureteral involvement. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Sarcoid of the testis

    Jaime A. Wong, John Grantmyre
    Canadian Journal of Urology, Vol.13, No.4, pp. 3201-3203, 2006
    Abstract Sarcoidosis is a chronic disease that rarely manifests in the male reproductive tract. Due to its infrequent nature, treatment for sarcoid of the male reproductive tract is controversial. We report a case of incidentally discovered sarcoid of the testis in a white male managed with a testis sparing approach. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Case report: renal lymphangiectasia

    Michael L. Pianezza1, Aiden Mokhtassi2, Louis Wu2, R. John D’A. Honey1
    Canadian Journal of Urology, Vol.13, No.4, pp. 3204-3207, 2006
    Abstract Renal lymphangiectasia is a rare renal condition. We present a case of bilateral renal lymphangiectasia in a 52-year-old man who presented with bilateral flank pain and gross hematuria. The clinical features, diagnosis and characteristic imaging findings are reviewed. This condition should be considered in the differential diagnosis of cystic renal masses in both children and adults. More >

Per Page:

Share Link